Micrornas - important molecules in lung cancer research

Frontiers in Genetics

Volumn 2, Issue JAN, 2012, Pages

  Leidinger, Petra ^a   Keller, Andreas ^a,b   Meese, Eckart ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SIEMENS AG   (Germany)

Author keywords

Biomarker; Blood; Bodyfluids; Diagnosis; Lungcancer; Microrna; Prognosis; Therapy

Indexed keywords

EID: 84876066393     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2011.00104     Document Type: Review

References (78)

1. Arora, H., Qureshi, R., Jin, S., Park, A. K., and Park, W. Y. (2011a). miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1. Exp. Mol. Med. 43, 298-304.
2. Arora, H., Qureshi, R., Park, A. K., and Park, W. Y. (2011b). Coordinated regulation of ATF2 by miR-26b in gamma-irradiated lung cancer cells. PLoS ONE 6, e23802. doi: 10.1371/journal.pone.0023802
3. Barshack, I., Lithwick-Yanai, G., Afek, A., Rosenblatt, K., Tabibian-Keissar, H., Zepeniuk, M., Cohen, L., Dan, H., Zion, O., Strenov, Y., Polak-Charcon, S., and Perelman, M. (2010). MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol. Res. Pract. 206, 578-584.
4. Bryant, J. L., Britson, J., Balko, J. M., Willian, M., Timmons, R., Frolov, A., and Black, E. P. (2011). A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT. Br. J. Cancer. doi: 10.1038/bjc.2011.465. [Epub ahead of print].
5. Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., and Croce, C. M. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 101, 2999-3004.
6. Cao, G., Huang, B., Liu, Z., Zhang, J., Xu, H., Xia, W., Li, J., Li, S., Chen, L., Ding, H., Zhao, Q., Fan, M., Shen, B., and Shao, N. (2010). Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem. Biophys. Res. Commun. 396, 978-982.
7. Chen, L. P., Lai, Y. D., Li, D. C., Zhu, X. N., Yang, P., Li, W. X., Zhu, W., Zhao, J., Li, X. D., Xiao, Y. M., Zhang, Y., Xing, X. M., Wang, Q., Zhang, B., Lin, Y. C., Zeng, J. L., Zhang, S. X., Liu, C. X., Li, Z. F., Zeng, X. W., Lin, Z. N., Zhuang, Z. X., and Chen, W. (2011a). Alpha4 is highly expressed in carcinogen-transformed human cells and primary human cancers. Oncogene 30, 2943-2953.
8. Chen, W. S., Hou, J. N., Guo, Y. B., Yang, H. L., Xie, C. M., Lin, Y. C., and She, Z. G. (2011b). Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway. J. Exp. Clin. Cancer Res. 30, 17.
9. Chen, X., Hu, Z., Wang, W., Ba, Y., Ma, L., Zhang, C., Wang, C., Ren, Z., Zhao, Y., Wu, S., Zhuang, R., Zhang, Y., Hu, H., Liu, C., Xu, L., Wang, J., Shen, H., Zhang, J., Zen, K., and Zhang, C. Y. (2011c). Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int. J. Cancer. doi: 10.1002/ijc.26177. [Epub ahead of print].
10. Chin, L. J., Ratner, E., Leng, S., Zhai, R., Nallur, S., Babar, I., Muller, R. U., Straka, E., Su, L., Burki, E. A., Crowell, R. E., Patel, R., Kulkarni, T., Homer, R., Zelterman, D., Kidd, K. K., Zhu, Y., Christiani, D. C., Belinsky, S. A., Slack, F. J., and Weidhaas, J. B. (2008). A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res. 68, 8535-8540.
11. Cho, W. C., Chow, A. S., and Au, J. S. (2011). MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol 8, 125-131.
12. Chu, H., Wang, M., Shi, D., Ma, L., Zhang, Z., Tong, N., Huo, X., Wang, W., Luo, D., and Gao, Y. (2011). Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS ONE 6, e18108. doi: 10.1371/journal.pone.0018108
13. Crawford, M., Batte, K., Yu, L., Wu, X., Nuovo, G. J., Marsh, C. B., Otterson, G. A., and Nana-Sinkam, S. P. (2009). MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem. Biophys. Res. Commun. 388, 483-489.
14. Crawford, M., Brawner, E., Batte, K., Yu, L., Hunter, M. G., Otterson, G. A., Nuovo, G., Marsh, C. B., and Nana-Sinkam, S. P. (2008). MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 373, 607-612.
15. Du, L., Schageman, J. J., Irnov, Girard, L., Hammond, S. M., Minna, J. D., Gazdar, A. F., and Pertsemlidis, A. (2010). MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs. J. Exp. Clin. Cancer Res. 29, 75.
16. Du, L., Schageman, J. J., Subauste, M. C., Saber, B., Hammond, S. M., Prudkin, L., Wistuba, II, Ji, L., Roth, J. A., Minna, J. D., and Pertsemlidis, A. (2009). miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol. Cancer Res. 7, 1234-1243.
17. Duan, W., Gao, L., Wu, X., Wang, L., Nana-Sinkam, S. P., Otterson, G. A., and Villalona-Calero, M. A. (2010). MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells. Int. J. Cancer 127, 313-320.
18. Ebi, H., Sato, T., Sugito, N., Hosono, Y., Yatabe, Y., Matsuyama, Y., Yamaguchi, T., Osada, H., Suzuki, M., and Takahashi, T. (2009). Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene 28, 3371-3379.
19. Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., Volinia, S., Guler, G., Morrison, C. D., Chan, K. K., Marcucci, G., Calin, G. A., Huebner, K., and Croce, C. M. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 104, 15805-15810.
20. Gallardo, E., Navarro, A., Vinolas, N., Marrades, R. M., Diaz, T., Gel, B., Quera, A., Bandres, E., Garcia-Foncillas, J., Ramirez, J., and Monzo, M. (2009). miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 30, 1903-1909.
21. Gao, W., Yu, Y., Cao, H., Shen, H., Li, X., Pan, S., and Shu, Y. (2010). Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed. Pharmacother. 64, 399-408.
22. Guan, H., Zhang, P., Liu, C., Zhang, J., Huang, Z., Chen, W., Chen, Z., Ni, N., Liu, Q., and Jiang, A. (2011). Characterization and functional analysis of the human microRNA let-7a2 promoter in lung cancer A549 cell lines. Mol. Biol. Rep. 38, 5327-5334.
23. Hanoun, N., Delpu, Y., Suriawinata, A. A., Bournet, B., Bureau, C., Selves, J., Tsongalis, G. J., Dufresne, M., Buscail, L., Cordelier, P., and Torrisani, J. (2010). The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin. Chem. 56, 1107-1118.
24. Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Yatabe, Y., Kawahara, K., Sekido, Y., and Takahashi, T. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65, 9628-9632.
25. Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., and Shen, H. (2010). Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28, 1721-1726.
26. Jeong, S. H., Wu, H. G., and Park, W. Y. (2009). LIN28B confers radio-resistance through the posttranscriptional control of KRAS. Exp. Mol. Med. 41, 912-918.
27. Jiang, L., Huang, Q., Chang, J., Wang, E., and Qiu, X. (2011). MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells. Exp. Lung Res. 37, 387-398.
28. Keller, A., Leidinger, P., Borries, A., Wendschlag, A., Wucherpfennig, F., Scheffler, M., Huwer, H., Lenhof, H. P., and Meese, E. (2009). miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9, 353. doi: 10.1186/1471-2407-9-353
29. Landi, M. T., Zhao, Y., Rotunno, M., Koshiol, J., Liu, H., Bergen, A. W., Rubagotti, M., Goldstein, A. M., Linnoila, I., Marincola, F. M., Tucker, M. A., Bertazzi, P. A., Pesatori, A. C., Caporaso, N. E., McShane, L. M., and Wang, E. (2010). MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin. Cancer Res. 16, 430-441.
30. Lebanony, D., Benjamin, H., Gilad, S., Ezagouri, M., Dov, A., Ashkenazi, K., Gefen, N., Izraeli, S., Rechavi, G., Pass, H., Nonaka, D., Li, J., Spector, Y., Rosenfeld, N., Chajut, A., Cohen, D., Aharonov, R., and Mansukhani, M. (2009). Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J. Clin. Oncol. 27, 2030-2037.
31. Lee, J., Li, Z., Brower-Sinning, R., and John, B. (2007). Regulatory circuit of human microRNA biogenesis. PLoS Comput. Biol. 3, e67. doi: 10.1371/journal.pcbi.0030067
32. Leidinger, P., Keller, A., Borries, A., Huwer, H., Rohling, M., Huebers, J., Lenhof, H. P., and Meese, E. (2011). Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 74, 41-47.
33. Li, Y. J., Zhang, Y. X., Wang, P. Y., Chi, Y. L., Zhang, C., Ma, Y., Lv, C. J., and Xie, S. Y. (2011). Regression of A549 lung cancer tumors by anti-miR-150 vector. Oncol. Rep. 27, 129-134.
34. Liu, B., Peng, X. C., Zheng, X. L., Wang, J., and Qin, Y. W. (2009a). MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66, 169-175.
35. Liu, X., Sempere, L. F., Galimberti, F., Freemantle, S. J., Black, C., Dragnev, K. H., Ma, Y., Fiering, S., Memoli, V., Li, H., DiRenzo, J., Korc, M., Cole, C. N., Bak, M., Kauppinen, S., and Dmitrovsky, E. (2009b). Uncovering growth-suppressive MicroRNAs in lung cancer. Clin. Cancer Res. 15, 1177-1183.
36. Liu, X., Sempere, L. F., Ouyang, H., Memoli, V. A., Andrew, A. S., Luo, Y., Demidenko, E., Korc, M., Shi, W., Preis, M., Dragnev, K. H., Li, H., Direnzo, J., Bak, M., Freemantle, S. J., Kauppinen, S., and Dmitrovsky, E. (2010). MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J. Clin. Invest. 120, 1298-1309.
37. Liu, X. G., Zhu, W. Y., Huang, Y. Y., Ma, L. N., Zhou, S. Q., Wang, Y. K., Zeng, F., Zhou, J. H., and Zhang, Y. K. (2011). High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med. Oncol. PMID: 21516486. [Epub ahead of print].
38. Nasser, M. W., Datta, J., Nuovo, G., Kutay, H., Motiwala, T., Majumder, S., Wang, B., Suster, S., Jacob, S. T., and Ghoshal, K. (2008). Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 283, 33394-33405.
39. Navon, R., Wang, H., Steinfeld, I., Tsalenko, A., Ben-Dor, A., and Yakhini, Z. (2009). Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS ONE 4, e8003. doi: 10.1371/journal.pone.0008003
40. Nishikawa, E., Osada, H., Okazaki, Y., Arima, C., Tomida, S., Tatematsu, Y., Taguchi, A., Shimada, Y., Yanagisawa, K., Yatabe, Y., Toyokuni, S., Sekido, Y., and Takahashi, T. (2011). miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res. 71, 6165-6173.
41. Park, S., Minai-Tehrani, A., Xu, C. X., Chang, S. H., Woo, M. A., Noh, M. S., Lee, E. S., Lim, H. T., An, G. H., Lee, K. H., Sung, H. J., Beck, G. R., and Cho, M. H. (2011). Suppression of A549 lung cancer cell migration by precursor let-7g microRNA. Mol. Med. Rep. 3, 1007-1013.
42. Patnaik, S. K., Kannisto, E., Knudsen, S., and Yendamuri, S. (2010). Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res. 70, 36-45.
43. Patnaik, S. K., Kannisto, E., Mallick, R., and Yendamuri, S. (2011). Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells. PLoS ONE 6, e22379. doi: 10.1371/journal.pone.0022379
44. Qin, A., Zhou, Y., Sheng, M., Fei, G., Ren, T., and Xu, L. (2011). Effects of microRNA-155 on the growth of human lung cancer cell line 95D in vitro. Zhongguo Fei Ai Za Zhi 14, 575-580.
45. Raponi, M., Dossey, L., Jatkoe, T., Wu, X., Chen, G., Fan, H., and Beer, D. G. (2009). MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 69, 5776-5783.
46. Roa, W., Brunet, B., Guo, L., Amanie, J., Fairchild, A., Gabos, Z., Nijjar, T., Scrimger, R., Yee, D., and Xing, J. (2010). Identification of a new microRNA expression profile as a potential cancer screening tool. Clin. Invest. Med. 33, E124.
47. Seike, M., Goto, A., Okano, T., Bowman, E. D., Schetter, A. J., Horikawa, I., Mathe, E. A., Jen, J., Yang, P., Sugimura, H., Gemma, A., Kudoh, S., Croce, C. M., and Harris, C. C. (2009). MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc. Natl. Acad. Sci. U.S.A. 106, 12085-12090.
48. Sempere, L. F., Liu, X., and Dmitrovsky, E. (2009). Tumor-suppressive microRNAs in Lung cancer: diagnostic and therapeutic opportunities. Sci. World J. 9, 626-628.
49. Shin, S., Cha, H. J., Lee, E. M., Lee, S. J., Seo, S. K., Jin, H. O., Park, I. C., Jin, Y. W., and An, S. (2009). Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int. J. Oncol. 35, 81-86.
50. Silva, J., Garcia, V., Zaballos, A., Provencio, M., Lombardia, L., Almonacid, L., Garcia, J. M., Dominguez, G., Pena, C., Diaz, R., Herrera, M., Varela, A., and Bonilla, F. (2011). Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur. Respir. J. 37, 617-623.
51. Sun, Y., Fang, R., Li, C., Li, L., Li, F., Ye, X., and Chen, H. (2010). Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem. Biophys. Res. Commun. 396, 501-507.
52. Takahashi, Y., Forrest, A. R., Maeno, E., Hashimoto, T., Daub, C. O., and Yasuda, J. (2009). MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS ONE 4, e6677. doi: 10.1371/journal.pone.0006677
53. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., Mitsudomi, T., and Takahashi, T. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753-3756.
54. Thu, K. L., Chari, R., Lockwood, W. W., Lam, S., and Lam, W. L. (2011). miR-101 DNA copy loss is a prominent subtype specific event in lung cancer. J. Thorac. Oncol. 6, 1594-1598.
55. Tian, T., Shu, Y., Chen, J., Hu, Z., Xu, L., Jin, G., Liang, J., Liu, P., Zhou, X., Miao, R., Ma, H., Chen, Y., and Shen, H. (2009). A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol. Biomarkers Prev. 18, 1183-1187.
56. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R. L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C. C., and Croce, C. M. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 103, 2257-2261.
57. Vosa, U., Vooder, T., Kolde, R., Fischer, K., Valk, K., Tonisson, N., Roosipuu, R., Vilo, J., Metspalu, A., and Annilo, T. (2011). Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer 50, 812-822.
58. Wang, G., Mao, W., and Zheng, S. (2008). MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett. 582, 3663-3668.
59. Wang, X., Ling, C., Bai, Y., and Zhao, J. (2010). MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat. Rec. (Hoboken) 294, 88-92.
60. Wang, X. C., Du, L. Q., Tian, L. L., Wu, H. L., Jiang, X. Y., Zhang, H., Li, D. G., Wang, Y. Y., Wu, H. Y., She, Y., Liu, Q. F., Fan, F. Y., and Meng, A. M. (2011a). Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 72, 92-99.
61. Wang, Z., Yang, J., Fisher, T., Xiao, H., Jiang, Y., and Yang, C. (2011b). Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells. Environ. Health Perspect. doi: 10.1289/ehp.1104061. [Epub ahead of print].
62. Weiss, G. J., Bemis, L. T., Nakajima, E., Sugita, M., Birks, D. K., Robinson, W. A., Varella-Garcia, M., Bunn, P. A. Jr., Haney, J., Helfrich, B. A., Kato, H., Hirsch, F. R., and Franklin, W. A. (2008). EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol. 19, 1053-1059.
63. Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., and Bader, A. G. (2010). Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 70, 5923-5930.
64. Xie, Y., Todd, N. W., Liu, Z., Zhan, M., Fang, H., Peng, H., Alattar, M., Deepak, J., Stass, S. A., and Jiang, F. (2010). Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 67, 170-176.
65. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., Calin, G. A., Liu, C. G., Croce, C. M., and Harris, C. C. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198.
66. Yang, Y., Ahn, Y. H., Gibbons, D. L., Zang, Y., Lin, W., Thilaganathan, N., Alvarez, C. A., Moreira, D. C., Creighton, C. J., Gregory, P. A., Goodall, G. J., and Kurie, J. M. (2011). The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J. Clin. Invest. 121, 1373-1385.
67. Yang, Y., Li, X., Yang, Q., Wang, X., Zhou, Y., Jiang, T., Ma, Q., and Wang, Y. J. (2010). The role of microRNA in human lung squamous cell carcinoma. Cancer Genet. Cytogenet. 200, 127-133.
68. Yin, R., Zhang, S., Wu, Y., Fan, X., Jiang, F., Zhang, Z., Feng, D., Guo, X., and Xu, L. (2011). microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4. Oncol. Rep. 25, 1747-1754.
69. Zhang, J., Zhang, T., Ti, X., Shi, J., Wu, C., Ren, X., and Yin, H. (2010a). Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem. Biophys. Res. Commun. 399, 1-6.
70. Zhang, J. G., Wang, J. J., Zhao, F., Liu, Q., Jiang, K., and Yang, G. H. (2010b). MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin. Chim. Acta 411, 846-852.
71. Zhang, L., Liu, T., Huang, Y., and Liu, J. (2011a). microRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-associated protein. Int. J. Mol. Med. 28, 381-388.
72. Zhang, S., Wu, Y., Feng, D., Zhang, Z., Jiang, F., Yin, R., and Xu, L. (2011b). miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene. Zhongguo Fei Ai Za Zhi 14, 317-322.
73. Zhang, Y., Ma, T., Yang, S., Xia, M., Xu, J., An, H., Yang, Y., and Li, S. (2011c). High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells. Mol. Cell. Biochem. 357, 363-371.
74. Zheng, D., Haddadin, S., Wang, Y., Gu, L. Q., Perry, M. C., Freter, C. E., and Wang, M. X. (2011). Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int. J. Clin. Exp. Pathol. 4, 575-586.
75. Zhong, M., Ma, X., Sun, C., and Chen, L. (2010). MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer. Chem. Biol. Interact. 184, 431-438.
76. Zhu, W., Liu, X., He, J., Chen, D., Hunag, Y., and Zhang, Y. K. (2011). Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 11, 393. doi: 10.1186/1471-2407-11-393
77. Zhu, W., Shan, X., Wang, T., Shu, Y., and Liu, P. (2010a). miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer 127, 2520-2529.
78. Zhu, W., Zhu, D., Lu, S., Wang, T., Wang, J., Jiang, B., Shu, Y., and Liu, P. (2010b). miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med. Oncol. doi: 10.1007/s12032-010-9797-4. [Epub ahead of print]